Aprotinina: ¿Un fármaco multifuncional?
El empleo de fármacos promotores de la hemostasia se considera de gran importancia adyuvante en el manejo del sangrado. En el momento de la publicación de este capítulo, la aprotinina, un fármaco básicamente antifibrinolítico, se consideraba un paso ...
Alcántara, Mª José, Llau, Juan V.
core
[Relevance of genetic polymorphisms in voriconazole neurotoxicity: case report in a pediatric patient]. [PDF]
Martín-Roldán A +3 more
europepmc +1 more source
[Safety in the selection of oral antibiotic treatment in community infections, beyond COVID-19]. [PDF]
Barberán J +2 more
europepmc +1 more source
[Depression in patients with epilepsy. Pathophysiological and clinical concepts and therapeutic strategies]. [PDF]
Paredes-Aragón E +2 more
europepmc +1 more source
[Selection of pharmacogenomic variants and methodology for their use in community pharmacy]. [PDF]
Montero-Gómez A, Sánchez Pozo A.
europepmc +1 more source
Comparative Analysis of Graph Attention and Graph Convolutional Networks for Predicting Candidate SNP-miRNA-DrugInteractions in Integrated Regulatory Datasets. [PDF]
Batra V, Yadalam PK, Ardila CM.
europepmc +1 more source
[Study of anticholinergic burden in chronic treatments of outpatients in the Community Pharmacy]. [PDF]
Zaragoza Noguera R +2 more
europepmc +1 more source
[Role of the Pharmacotherapeutic Monitoring Service (PMS) of the Community Pharmacy in the detection and resolution of adverse reactions to statins linked to possible diagnostic errors in elderly patients]. [PDF]
García Martín DL.
europepmc +1 more source

